Loading…

Role of Plasminogen Activator Inhibitor-1 in Promoting Fibrin Deposition in Rabbits Infused with Ancrod or Thrombin

The role of defective, fibrinolysis caused by elevated activity of plasminogen activator inhibitor-1 (PAI-1) in promoting fibrin deposition in vivo has not been well established. The present study compared the efficacy of thrombin or ancrod, a venom-derived enzyme that clots fibrinogen, to induce fi...

Full description

Saved in:
Bibliographic Details
Main Authors: Krishnamurti, Chitra, Bolan, Charles, Colleton, Curtis A, Reilly, Thomas M, Alving, Barbara M
Format: Report
Language:English
Subjects:
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Krishnamurti, Chitra
Bolan, Charles
Colleton, Curtis A
Reilly, Thomas M
Alving, Barbara M
description The role of defective, fibrinolysis caused by elevated activity of plasminogen activator inhibitor-1 (PAI-1) in promoting fibrin deposition in vivo has not been well established. The present study compared the efficacy of thrombin or ancrod, a venom-derived enzyme that clots fibrinogen, to induce fibrin formation in rabbits with elevated PAI-1 levels. One set of male New Zealand rabbits received intravenous endotoxin to increase endogenous PAI-1 activity followed by a 1 -hour infusion of ancrod or thrombin; another set of normal rabbits received intravenous human recombinant PAI-1 (rPAI-1) during an infusion of ancrod or thrombin. Thirty minutes after the end of the infusion, renal fibrin deposition was assessed by histopathology. Animals receiving endotoxin, rPAI-1 , ancrod, or thrombin alone did not develop renal thrombi. Pub. in Blood, v82, n12, p3631-3636, 15 Dec 1993.
format report
fullrecord <record><control><sourceid>dtic_1RU</sourceid><recordid>TN_cdi_dtic_stinet_ADA275301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ADA275301</sourcerecordid><originalsourceid>FETCH-dtic_stinet_ADA2753013</originalsourceid><addsrcrecordid>eNqFjLEOgkAQRGksjPoHFvsDJCIx1heRaEcIPbmDAzaBXXN76u-7JvZWM5k3M-tEap498ADVbGVB4tETmC7iy0YOcKcJHapLM0CCKvDCEWmEEl3QoPAPFozI9MW1dVoWXQ1P8T28MU5gqAvcg541k84d0jZZDXYWv_vpJtmX1-ZyS_uIXSv672NrCnM8n_JDlv_BHw6-QKI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>Role of Plasminogen Activator Inhibitor-1 in Promoting Fibrin Deposition in Rabbits Infused with Ancrod or Thrombin</title><source>DTIC Technical Reports</source><creator>Krishnamurti, Chitra ; Bolan, Charles ; Colleton, Curtis A ; Reilly, Thomas M ; Alving, Barbara M</creator><creatorcontrib>Krishnamurti, Chitra ; Bolan, Charles ; Colleton, Curtis A ; Reilly, Thomas M ; Alving, Barbara M ; WALTER REED ARMY INST OF RESEARCH WASHINGTON DC</creatorcontrib><description>The role of defective, fibrinolysis caused by elevated activity of plasminogen activator inhibitor-1 (PAI-1) in promoting fibrin deposition in vivo has not been well established. The present study compared the efficacy of thrombin or ancrod, a venom-derived enzyme that clots fibrinogen, to induce fibrin formation in rabbits with elevated PAI-1 levels. One set of male New Zealand rabbits received intravenous endotoxin to increase endogenous PAI-1 activity followed by a 1 -hour infusion of ancrod or thrombin; another set of normal rabbits received intravenous human recombinant PAI-1 (rPAI-1) during an infusion of ancrod or thrombin. Thirty minutes after the end of the infusion, renal fibrin deposition was assessed by histopathology. Animals receiving endotoxin, rPAI-1 , ancrod, or thrombin alone did not develop renal thrombi. Pub. in Blood, v82, n12, p3631-3636, 15 Dec 1993.</description><language>eng</language><subject>ANIMALS ; Biochemistry ; BLOOD COAGULATION ; DEPOSITION ; ENDOTOXINS ; ENZYME PRECURSORS ; ENZYMES ; FIBRIN ; FIBRINOGEN ; FIBRINOLYSIS ; HISTOPATHOLOGY ; HUMANS ; IN VIVO ANALYSIS ; INFUSIONS ; INHIBITORS ; MALES ; NEW ZEALAND ; PHYSIOLOGY ; RABBITS ; REPRINTS ; THROMBIN ; VENOMS</subject><creationdate>1993</creationdate><rights>Approved for public release; distribution is unlimited.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,776,881,27543,27544</link.rule.ids><linktorsrc>$$Uhttps://apps.dtic.mil/sti/citations/ADA275301$$EView_record_in_DTIC$$FView_record_in_$$GDTIC$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Krishnamurti, Chitra</creatorcontrib><creatorcontrib>Bolan, Charles</creatorcontrib><creatorcontrib>Colleton, Curtis A</creatorcontrib><creatorcontrib>Reilly, Thomas M</creatorcontrib><creatorcontrib>Alving, Barbara M</creatorcontrib><creatorcontrib>WALTER REED ARMY INST OF RESEARCH WASHINGTON DC</creatorcontrib><title>Role of Plasminogen Activator Inhibitor-1 in Promoting Fibrin Deposition in Rabbits Infused with Ancrod or Thrombin</title><description>The role of defective, fibrinolysis caused by elevated activity of plasminogen activator inhibitor-1 (PAI-1) in promoting fibrin deposition in vivo has not been well established. The present study compared the efficacy of thrombin or ancrod, a venom-derived enzyme that clots fibrinogen, to induce fibrin formation in rabbits with elevated PAI-1 levels. One set of male New Zealand rabbits received intravenous endotoxin to increase endogenous PAI-1 activity followed by a 1 -hour infusion of ancrod or thrombin; another set of normal rabbits received intravenous human recombinant PAI-1 (rPAI-1) during an infusion of ancrod or thrombin. Thirty minutes after the end of the infusion, renal fibrin deposition was assessed by histopathology. Animals receiving endotoxin, rPAI-1 , ancrod, or thrombin alone did not develop renal thrombi. Pub. in Blood, v82, n12, p3631-3636, 15 Dec 1993.</description><subject>ANIMALS</subject><subject>Biochemistry</subject><subject>BLOOD COAGULATION</subject><subject>DEPOSITION</subject><subject>ENDOTOXINS</subject><subject>ENZYME PRECURSORS</subject><subject>ENZYMES</subject><subject>FIBRIN</subject><subject>FIBRINOGEN</subject><subject>FIBRINOLYSIS</subject><subject>HISTOPATHOLOGY</subject><subject>HUMANS</subject><subject>IN VIVO ANALYSIS</subject><subject>INFUSIONS</subject><subject>INHIBITORS</subject><subject>MALES</subject><subject>NEW ZEALAND</subject><subject>PHYSIOLOGY</subject><subject>RABBITS</subject><subject>REPRINTS</subject><subject>THROMBIN</subject><subject>VENOMS</subject><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>1993</creationdate><recordtype>report</recordtype><sourceid>1RU</sourceid><recordid>eNqFjLEOgkAQRGksjPoHFvsDJCIx1heRaEcIPbmDAzaBXXN76u-7JvZWM5k3M-tEap498ADVbGVB4tETmC7iy0YOcKcJHapLM0CCKvDCEWmEEl3QoPAPFozI9MW1dVoWXQ1P8T28MU5gqAvcg541k84d0jZZDXYWv_vpJtmX1-ZyS_uIXSv672NrCnM8n_JDlv_BHw6-QKI</recordid><startdate>19931215</startdate><enddate>19931215</enddate><creator>Krishnamurti, Chitra</creator><creator>Bolan, Charles</creator><creator>Colleton, Curtis A</creator><creator>Reilly, Thomas M</creator><creator>Alving, Barbara M</creator><scope>1RU</scope><scope>BHM</scope></search><sort><creationdate>19931215</creationdate><title>Role of Plasminogen Activator Inhibitor-1 in Promoting Fibrin Deposition in Rabbits Infused with Ancrod or Thrombin</title><author>Krishnamurti, Chitra ; Bolan, Charles ; Colleton, Curtis A ; Reilly, Thomas M ; Alving, Barbara M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-dtic_stinet_ADA2753013</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>1993</creationdate><topic>ANIMALS</topic><topic>Biochemistry</topic><topic>BLOOD COAGULATION</topic><topic>DEPOSITION</topic><topic>ENDOTOXINS</topic><topic>ENZYME PRECURSORS</topic><topic>ENZYMES</topic><topic>FIBRIN</topic><topic>FIBRINOGEN</topic><topic>FIBRINOLYSIS</topic><topic>HISTOPATHOLOGY</topic><topic>HUMANS</topic><topic>IN VIVO ANALYSIS</topic><topic>INFUSIONS</topic><topic>INHIBITORS</topic><topic>MALES</topic><topic>NEW ZEALAND</topic><topic>PHYSIOLOGY</topic><topic>RABBITS</topic><topic>REPRINTS</topic><topic>THROMBIN</topic><topic>VENOMS</topic><toplevel>online_resources</toplevel><creatorcontrib>Krishnamurti, Chitra</creatorcontrib><creatorcontrib>Bolan, Charles</creatorcontrib><creatorcontrib>Colleton, Curtis A</creatorcontrib><creatorcontrib>Reilly, Thomas M</creatorcontrib><creatorcontrib>Alving, Barbara M</creatorcontrib><creatorcontrib>WALTER REED ARMY INST OF RESEARCH WASHINGTON DC</creatorcontrib><collection>DTIC Technical Reports</collection><collection>DTIC STINET</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Krishnamurti, Chitra</au><au>Bolan, Charles</au><au>Colleton, Curtis A</au><au>Reilly, Thomas M</au><au>Alving, Barbara M</au><aucorp>WALTER REED ARMY INST OF RESEARCH WASHINGTON DC</aucorp><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><btitle>Role of Plasminogen Activator Inhibitor-1 in Promoting Fibrin Deposition in Rabbits Infused with Ancrod or Thrombin</btitle><date>1993-12-15</date><risdate>1993</risdate><abstract>The role of defective, fibrinolysis caused by elevated activity of plasminogen activator inhibitor-1 (PAI-1) in promoting fibrin deposition in vivo has not been well established. The present study compared the efficacy of thrombin or ancrod, a venom-derived enzyme that clots fibrinogen, to induce fibrin formation in rabbits with elevated PAI-1 levels. One set of male New Zealand rabbits received intravenous endotoxin to increase endogenous PAI-1 activity followed by a 1 -hour infusion of ancrod or thrombin; another set of normal rabbits received intravenous human recombinant PAI-1 (rPAI-1) during an infusion of ancrod or thrombin. Thirty minutes after the end of the infusion, renal fibrin deposition was assessed by histopathology. Animals receiving endotoxin, rPAI-1 , ancrod, or thrombin alone did not develop renal thrombi. Pub. in Blood, v82, n12, p3631-3636, 15 Dec 1993.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_dtic_stinet_ADA275301
source DTIC Technical Reports
subjects ANIMALS
Biochemistry
BLOOD COAGULATION
DEPOSITION
ENDOTOXINS
ENZYME PRECURSORS
ENZYMES
FIBRIN
FIBRINOGEN
FIBRINOLYSIS
HISTOPATHOLOGY
HUMANS
IN VIVO ANALYSIS
INFUSIONS
INHIBITORS
MALES
NEW ZEALAND
PHYSIOLOGY
RABBITS
REPRINTS
THROMBIN
VENOMS
title Role of Plasminogen Activator Inhibitor-1 in Promoting Fibrin Deposition in Rabbits Infused with Ancrod or Thrombin
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T21%3A23%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-dtic_1RU&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.btitle=Role%20of%20Plasminogen%20Activator%20Inhibitor-1%20in%20Promoting%20Fibrin%20Deposition%20in%20Rabbits%20Infused%20with%20Ancrod%20or%20Thrombin&rft.au=Krishnamurti,%20Chitra&rft.aucorp=WALTER%20REED%20ARMY%20INST%20OF%20RESEARCH%20WASHINGTON%20DC&rft.date=1993-12-15&rft_id=info:doi/&rft_dat=%3Cdtic_1RU%3EADA275301%3C/dtic_1RU%3E%3Cgrp_id%3Ecdi_FETCH-dtic_stinet_ADA2753013%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true